Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Issue 1 (2nd January 2020) - McIlroy, Graham; Nikolousis, Emmanouil; Abou-Zeid, Nervana; Shankara, Paneesha; Kishore, Bhuvan; Kaparou, Maria; Lovell, Richard; Elmoamly, Shereef; Davies, David; Horgan, Claire; Shenouda, Amir; Kanellopoulos, Alexandros